[go: up one dir, main page]

ATE479756T1 - Streptococcus pneumoniae-antigene und impfstoffe - Google Patents

Streptococcus pneumoniae-antigene und impfstoffe

Info

Publication number
ATE479756T1
ATE479756T1 AT06026300T AT06026300T ATE479756T1 AT E479756 T1 ATE479756 T1 AT E479756T1 AT 06026300 T AT06026300 T AT 06026300T AT 06026300 T AT06026300 T AT 06026300T AT E479756 T1 ATE479756 T1 AT E479756T1
Authority
AT
Austria
Prior art keywords
streptococcus pneumoniae
vaccines
relates
polypeptides
pneumoniae antigens
Prior art date
Application number
AT06026300T
Other languages
English (en)
Inventor
Charles Kunsch
Gil Choi
Steven Barash
Patrick Dillon
Michael Fannon
Craig Rosen
Brian Dougherty
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21851789&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE479756(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Application granted granted Critical
Publication of ATE479756T1 publication Critical patent/ATE479756T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06026300T 1996-10-31 1997-10-30 Streptococcus pneumoniae-antigene und impfstoffe ATE479756T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2996096P 1996-10-31 1996-10-31

Publications (1)

Publication Number Publication Date
ATE479756T1 true ATE479756T1 (de) 2010-09-15

Family

ID=21851789

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97946850T ATE348887T1 (de) 1996-10-31 1997-10-30 Streptococcus pneumoniae antigene und impfstoffe
AT06026300T ATE479756T1 (de) 1996-10-31 1997-10-30 Streptococcus pneumoniae-antigene und impfstoffe

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT97946850T ATE348887T1 (de) 1996-10-31 1997-10-30 Streptococcus pneumoniae antigene und impfstoffe

Country Status (11)

Country Link
US (9) US7056510B1 (de)
EP (4) EP1770164B1 (de)
JP (6) JP4469026B2 (de)
AT (2) ATE348887T1 (de)
AU (6) AU6909098A (de)
CA (2) CA2269663A1 (de)
DE (2) DE69737125T3 (de)
DK (1) DK0942983T4 (de)
ES (2) ES2350491T3 (de)
PT (1) PT942983E (de)
WO (2) WO1998018931A2 (de)

Families Citing this family (337)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
WO1997030070A1 (en) * 1996-02-20 1997-08-21 Smithkline Beecham Corporation Novel compounds
GB9608000D0 (en) * 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
GB9607993D0 (en) * 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
GB9607991D0 (en) * 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
US5968777A (en) * 1996-04-18 1999-10-19 Smithkline Beecham Corporation DNA encoding seryl t-RNA synthetase
US5795758A (en) * 1997-04-18 1998-08-18 Smithkline Beecham Corporation DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
US6270999B1 (en) 1997-04-10 2001-08-07 Smithkline Beecham Corporation Compounds
US5834276A (en) * 1996-04-18 1998-11-10 Smithkline Beecham Corporation Asparaginyl TRNA synthetase polynucleotides of streptococcus
JP2000509984A (ja) * 1996-05-01 2000-08-08 スミスクライン・ビーチャム・コーポレイション 新規化合物
US6165989A (en) * 1996-05-14 2000-12-26 Smithkline Beecham Corporation Era of Streptococcus pneumoniae
WO1997043304A1 (en) * 1996-05-14 1997-11-20 Smithkline Beecham Corporation Novel compounds
US5712108A (en) * 1996-05-29 1998-01-27 Eli Lilly And Company Peptidoglycan biosynthetic mure protein from streptocuccus pneumoniae
US5681694A (en) * 1996-06-18 1997-10-28 Eli Lilly And Company Murd protein method and kit for identification of inhibitors
EP0816502A3 (de) * 1996-07-03 1999-10-20 Smithkline Beecham Corporation Mur A-1, ein UDP-N-Acetylglucosamine-Enolpyruvyltransferase, aus Streptococcus pneumoniae
GB9613907D0 (en) 1996-07-03 1996-09-04 Smithkline Beecham Plc Novel compounds
US5776733A (en) * 1996-07-25 1998-07-07 Eli Lilly And Company Biosynthetic gene DD1 from Streptococcus pneumoniae
US5691161A (en) * 1996-08-01 1997-11-25 Eli Lilly And Company Peptidoglycan biosynthetic mura protein from Streptococcus pneumoniae
US6165762A (en) 1996-08-16 2000-12-26 Smithkline Beecham Corporation DNA encoding adenine phosphoribosyltransferase from Streptococcus pneumoniae
US5858718A (en) * 1997-07-08 1999-01-12 Smithkline Beecham Corporation Pcr a
US6284878B1 (en) 1996-08-16 2001-09-04 Smithkline Beecham Corporation def1
EP0956289A4 (de) * 1996-08-16 2004-10-13 Smithkline Beecham Corp Prokaryotische polynucleotide, polypeptide und ihre verwendung
GB9619071D0 (en) 1996-09-12 1996-10-23 Smithkline Beecham Plc Novel compounds
US5928895A (en) * 1996-09-24 1999-07-27 Smithkline Beecham Corporation IgA Fc binding protein
US5882896A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
US5882871A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation Saliva binding protein
US6225083B1 (en) * 1996-10-01 2001-05-01 Smithkline Beecham Corporation FtsL from Streptococcus pneumoniae
US5910414A (en) * 1996-10-15 1999-06-08 Smithkline Beecham Corporation Topoisomerase I of streptococcus pneumoniae
US5789202A (en) * 1996-10-17 1998-08-04 Eli Lilly And Company DNA encoding a novel penicillin binding protein from streptococcus pneumoniae
US6096518A (en) * 1996-10-24 2000-08-01 Smithkline Beecham Corporation DNA encoding SPO/REL polypeptides of streptococcus
US6022710A (en) * 1996-10-25 2000-02-08 Smithkline Beecham Corporation Nucleic acid encoding greA from Streptococcus pneumoniae
US6887663B1 (en) * 1996-10-31 2005-05-03 Human Genome Sciences, Inc. Streptococcus pneumoniae SP036 polynucleotides
CA2269663A1 (en) 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae antigens and vaccines
US5821335A (en) * 1996-11-19 1998-10-13 Eli Lilly And Company Biosynthetic gene murg from streptococcus pneumoniae
US5786197A (en) * 1996-11-25 1998-07-28 Smithkline Beecham Corporation lep
US6287803B1 (en) * 1996-11-27 2001-09-11 Smithkline Beecham Corporation Polynucleotides encoding a novel era polypeptide
US5948645A (en) * 1996-12-04 1999-09-07 Eli Lilly And Company Biosynthetic gene muri from Streptococcus pneumoniae
EP0854188A3 (de) * 1997-01-21 2000-02-09 Smithkline Beecham Streptococcus pneumoniae aroE Polypeptiden und Polynuleotiden
EP0863205A1 (de) * 1997-02-10 1998-09-09 Smithkline Beecham Corporation Protein Def2 aus Streptococcus pneumoniae
EP0863152A3 (de) * 1997-02-10 2000-04-19 Smithkline Beecham Corporation Streptococcus pneumoniae Protein Def1
US6228838B1 (en) * 1997-02-28 2001-05-08 Smithkline Beecham Corporation LicD1 polypeptides
US6110899A (en) * 1997-02-28 2000-08-29 Smithkline Beecham Corporation LICC of Streptococcus pneumoniae
CA2230497A1 (en) * 1997-02-28 1998-08-28 Smithkline Beecham Corporation Novel lica
US5962295A (en) * 1997-02-28 1999-10-05 Smithkline Beecham Corporation LicB polypeptides from Streptococcus pneumoniae
DE19708537A1 (de) * 1997-03-03 1998-09-10 Biotechnolog Forschung Gmbh Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc.
US6074858A (en) * 1997-04-18 2000-06-13 Smithkline Beecham Corporation Cysteinyl TRNA synthetase from Streptococcus pneumoniae
US6210940B1 (en) 1997-04-18 2001-04-03 Smithkline Beecham Corporation Compounds
AU740153B2 (en) * 1997-04-24 2001-11-01 Regents Of The University Of Minnesota Human complement C3-degrading proteinase from streptococcus pneumoniae
US6676943B1 (en) 1997-04-24 2004-01-13 Regents Of The University Of Minnesota Human complement C3-degrading protein from Streptococcus pneumoniae
US5919664A (en) * 1997-05-29 1999-07-06 Smithkline Beecham Corporation Peptide release factor, prfC (RF-3), a GTP-Binding protein
US6165991A (en) * 1997-05-30 2000-12-26 Smithkline Beecham Corporation Sensor histidine kinase of Streptococcus pneumoniae
US6287836B1 (en) * 1997-05-30 2001-09-11 Smithkline Beecham Corporation Histidine kinase from Streptococcus pneumoniae and compositions therecontaining
US6165992A (en) * 1997-05-30 2000-12-26 Smithkline Beecham Corporation Histidine kinase
CA2233577A1 (en) * 1997-05-30 1998-11-30 Smithkline Beecham Corporation Histidine kinase
US5866365A (en) * 1997-06-05 1999-02-02 Smithkline Beecham Corporation RNC polynucleotides
US5882889A (en) * 1997-06-13 1999-03-16 Smithkline Beecham Corporation Response regulator in a two component signal transduction system
US6270991B1 (en) 1997-06-20 2001-08-07 Smithkline Beecham Corporation Histidine kinase
US6268172B1 (en) * 1997-06-20 2001-07-31 Smithkline Beecham Corporation Compounds
EP0885903A3 (de) * 1997-06-20 2000-01-19 Smithkline Beecham Corporation Nukleinsäure kodierend für Streptococcus pneumoniae Response-Regulator
EP0885965A3 (de) * 1997-06-20 2000-01-12 Smithkline Beecham Corporation Histidin kinase polypeptide
EP0885963A3 (de) * 1997-06-20 1999-12-29 Smithkline Beecham Corporation Zusammensetzungen enthaltend Polypeptide und Polynucleotide aus Streptococcus pneumoniae, besagte Polypeptide sind mittels ihrer Aminosäurensequenz mit SapR Polypeptid aus Streptococcus mutans verwandt
US6140061A (en) * 1997-06-20 2000-10-31 Smithkline Beecham Corporation Response regulator
EP0885966A3 (de) * 1997-06-20 1999-12-29 Smithkline Beecham Corporation Neue Verbindungen
EP0891984A3 (de) * 1997-06-20 2000-01-19 Smithkline Beecham Corporation Nukleinsäure kodierend für streptococcus pneumoniae response-regulator
US5866366A (en) * 1997-07-01 1999-02-02 Smithkline Beecham Corporation gidB
CA2236441A1 (en) * 1997-07-01 1999-01-01 Smithkline Beecham Corporation Gida2
US6238882B1 (en) * 1997-07-01 2001-05-29 Smithkline Beecham Corporation GidA1
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US7153952B1 (en) 1997-07-02 2006-12-26 sanofi pasteur limited/sanofi pasteur limitée Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
EP0890641A1 (de) * 1997-07-10 1999-01-13 Smithkline Beecham Corporation Neues IspA
EP0915159A1 (de) * 1997-07-17 1999-05-12 Smithkline Beecham Corporation Neue Xanthin-Phosphoribosyltransferase
CA2237043A1 (en) * 1997-07-18 1999-01-18 Smithkline Beecham Corporation Response regulator
US5994101A (en) * 1997-07-18 1999-11-30 Smithkline Beecham Corporation DNA encoding gidA1 polypeptides
EP0894857A3 (de) * 1997-08-01 2001-09-26 Smithkline Beecham Corporation SecA Gen aus Streptococcus pneumoniae
US5840538A (en) * 1997-08-06 1998-11-24 Smithkline Beecham Corporation Lgt
EP0896061A3 (de) * 1997-08-08 2000-07-26 Smithkline Beecham Corporation RpoA Gen aus Staphylococcus aureus
US6197300B1 (en) * 1997-08-12 2001-03-06 Smithkline Beecham Corporation ftsZ
US5929045A (en) * 1997-08-12 1999-07-27 Smithkline Beecham Corporation Recombinant expression of polynucleotides encoding the UDP-N-acetylmuramoylalanine:D-glutamate ligase (MurD) of Streptococcus pneumoniae
US5888770A (en) * 1997-08-26 1999-03-30 Smithkline Beecham Corporation Spoiiie
US6072032A (en) * 1997-08-29 2000-06-06 Smithkline Beecham Corporation FtsY polypeptides from Streptococcus pneumoniae
US5882898A (en) * 1997-08-29 1999-03-16 Smithkline Beecham Corporation Streptococcus pneumoniae polynucleotides which encode folyl-polyglutamate synthetase (FPGS) polypeptides
US6225087B1 (en) * 1997-09-09 2001-05-01 Smithkline Beecham Corporation Response regulator
EP0902087A3 (de) * 1997-09-10 2000-03-15 SmithKline Beecham Corporation Histidine kinase
EP0913478A3 (de) * 1997-09-17 1999-12-29 Smithkline Beecham Corporation Histidin Kinase von Streptococcus pneumoniae 0100993
US5866369A (en) * 1997-09-18 1999-02-02 Smithkline Beecham Corporation Amps
US5885804A (en) * 1997-09-18 1999-03-23 Smithkline Beecham Corporation PhoH
CA2305016A1 (en) * 1997-09-24 1999-04-01 Regents Of The University Of Minnesota Human complement c3-degrading proteinase from streptococcus pneumoniae
EP0905249A3 (de) * 1997-09-25 1999-08-04 Smithkline Beecham Corporation Alkohol Dehydrogenase
US6194170B1 (en) 1997-09-25 2001-02-27 Smithkline Beecham Corporation MurF of Streptococcus pneumoniae
CA2244954A1 (en) * 1997-09-25 1999-03-25 Smithkline Beecham Corporation Murf
US6121028A (en) * 1997-10-10 2000-09-19 Smithkline Beecham Corporation MurE
US6331411B1 (en) * 1997-10-14 2001-12-18 Smithkline Beecham Corporation TopA
EP0913479A3 (de) * 1997-10-27 2000-10-25 Smithkline Beecham Corporation Adenin Glycosylase
US5861281A (en) 1997-10-30 1999-01-19 Smithkline Beecham Corporation Lacc
US6165763A (en) 1997-10-30 2000-12-26 Smithkline Beecham Corporation Ornithine carbamoyltransferase
EP0913480A3 (de) * 1997-11-03 2001-07-11 Smithkline Beecham Corporation Chorismat Synthase
EP0964921A4 (de) * 1997-11-05 2002-01-23 Smithkline Beecham Corp Neue ers aus streptococcus
US20020058799A1 (en) * 1998-05-18 2002-05-16 Sanjoy Biswas Novel pth
EP1042480A1 (de) * 1997-12-31 2000-10-11 Stressgen Biotechnologies Corporation Streptokokken-hitzeschock-proteine, mitglieder der hsp60-familie
WO1999033871A2 (en) * 1997-12-31 1999-07-08 Millennium Pharmaceuticals, Inc. Essential bacterial genes and their use
CZ301056B6 (cs) * 1998-02-20 2009-10-29 Id Biomedical Corporation Antigeny streptokoku skupiny B
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
BR9909483A (pt) * 1998-04-07 2001-10-09 Medimmune Inc Derivados de proteìnas ligantes pneumococcal colina para vacinas
TR200003498T2 (tr) * 1998-04-07 2001-10-22 St. Jude Children's Research Hospital Amino asit sekansından oluşan bir polipetit, bunun aşıları ve kullanımları
GB9808363D0 (en) * 1998-04-22 1998-06-17 Glaxo Group Ltd Bacterial polypeptide family
GB9808350D0 (en) * 1998-04-22 1998-06-17 Glaxo Group Ltd Bacterial polypeptide family
US20010016200A1 (en) * 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
JP2002515240A (ja) * 1998-05-18 2002-05-28 スミスクライン・ビーチャム・コーポレイション ストレプトコッカス・ニュモニエのｃｌｐＸ
WO1999061452A2 (en) * 1998-05-28 1999-12-02 Smithkline Beecham Corporation acpS
US6190881B1 (en) * 1998-06-05 2001-02-20 Smithkline Beecham Corporation Ribonucleotide diphosphate reductase, nrdF, of streptococcus pneumoniae
US6660520B2 (en) * 1998-06-05 2003-12-09 Smithkline Beecham Corporation Nrde
WO1999064610A1 (en) * 1998-06-11 1999-12-16 St. Jude Children's Research Hospital ZmpB, A NEW DETERMINANT OF VIRULENCE FOR STREPTOCOCCUS PNEUMONIAE, VACCINE DERIVED THEREFROM AND USES THEREOF
WO2000001801A1 (en) * 1998-07-02 2000-01-13 Smithkline Beecham Corporation Ftsz multimeric proteins and their uses
JP2002521026A (ja) * 1998-07-24 2002-07-16 スミスクライン・ビーチャム・コーポレイション ニュモコッカスｎｒｄｇ蛋白
US7098182B2 (en) 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
JP2002531054A (ja) * 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド Ｂ群連鎖球菌由来の核酸およびタンパク質
EP1783224A3 (de) * 1998-07-27 2007-08-15 Sanofi Pasteur Limited Streptococcus pneumoniae Proteine und Nukleinsäuren
US6936252B2 (en) * 1998-07-27 2005-08-30 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
EP1801218A3 (de) * 1998-07-27 2007-10-10 Sanofi Pasteur Limited Nukleinsäuren und Proteine aus Pneumokokken
EP1624064A3 (de) * 1998-07-27 2006-05-10 Microbial Technics Limited Nukleinsäuren und entsprechende Proteine aus streptococcus pneumoniae
EP1144640A3 (de) * 1998-07-27 2001-11-28 Microbial Technics Limited Nukleinsaüren und entsprechende proteine aus streptococcus pneumoniae
ATE361365T1 (de) * 1998-07-27 2007-05-15 Sanofi Pasteur Ltd Streptococcus pneumoniae proteine und nukleinsäuren
US20030134407A1 (en) 1998-07-27 2003-07-17 Le Page Richard William Falla Nucleic acids and proteins from Streptococcus pneumoniae
JP2002524069A (ja) 1998-09-09 2002-08-06 ミレニアム ファーマシューティカルズ インク． 必須細菌遺伝子およびその使用
US6268177B1 (en) 1998-09-22 2001-07-31 Smithkline Beecham Corporation Isolated nucleic acid encoding nucleotide pyrophosphorylase
US6225457B1 (en) * 1998-09-23 2001-05-01 Smithkline Beecham Corporation murF2
IL142017A0 (en) * 1998-09-24 2002-03-10 Univ Minnesota Human complement c3-degrading polypeptide from streptococcus pneumoniae
US20030082614A1 (en) * 2001-05-29 2003-05-01 Sanjoy Biswas Map
JP2002525101A (ja) * 1998-09-28 2002-08-13 スミスクライン・ビーチャム・コーポレイション Ｍａｐ
US6515119B1 (en) * 1998-09-30 2003-02-04 Millennium Pharmaceuticals, Inc. Use of S-ydcB and B-ydcB, essential bacterial genes
US6537774B1 (en) 1998-10-14 2003-03-25 Smithkline Beecham Corporation UPS (undecaprenyl diphosphate synthase
US6255075B1 (en) 1998-10-20 2001-07-03 Smithkline Beecham Corporation Bira
US6110685A (en) * 1998-10-28 2000-08-29 Smithkline Beecham Corporation infB
US6228625B1 (en) * 1998-11-03 2001-05-08 Smithkline Beecham Corporation metK from Streptococcus pneumoniae
WO2000026359A1 (en) * 1998-11-04 2000-05-11 Smithkline Beecham Corporation ftsX
US6165764A (en) * 1998-11-09 2000-12-26 Smithkline Beecham Corporation Polynucleotides encoding tRNA methyl transferases from Streptococcus pneumoniae
US6495139B2 (en) * 1998-11-19 2002-12-17 St. Jude Children's Research Hospital Identification and characterization of novel pneumococcal choline binding protein, CBPG, and diagnostic and therapeutic uses thereof
AU2027400A (en) * 1998-11-19 2000-06-05 St. Jude Children's Research Hospital Identification and characterization of novel pneumococcal choline binding proteins, cbpg and cbpd, and diagnostic and therapeutic uses thereof
US6277595B1 (en) * 1998-11-19 2001-08-21 Smithkline Beecham Corporation FabZ
US6582706B1 (en) * 1998-12-21 2003-06-24 Medimmune, Inc. Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS
AU2004242430C1 (en) * 1998-12-21 2008-06-05 Med Immune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
EA004444B1 (ru) 1998-12-22 2004-04-29 Майкросайенс Лимитед Гены и белки и их применение
AP2006003504A0 (en) * 1998-12-22 2006-02-28 Microscience Ltd Outer surface proteins, their genes, and their use.
EP1950302B1 (de) 1998-12-23 2012-12-05 ID Biomedical Corporation of Quebec Streptokokken-Antigene
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
ES2480417T3 (es) * 1998-12-23 2014-07-28 Id Biomedical Corporation Of Quebec Antígenos nuevos de estreptococos
AU2005209689B2 (en) * 1998-12-23 2008-07-17 Id Biomedical Corporation Of Quebec Novel streptococcus antigens
US6340564B1 (en) 1999-01-26 2002-01-22 Smithkline Beecham Corporation yhxB
WO2000044764A1 (en) * 1999-01-28 2000-08-03 Smithkline Beecham Corporation Mvd
US6346396B1 (en) * 1999-01-29 2002-02-12 Jianzhong Huang MurA
US6306633B1 (en) 1999-02-01 2001-10-23 Smithkline Beecham Corporation Polynucleotides encoding mevalonate kinase from Streptococcus pneumoniae
WO2000049033A1 (en) * 1999-02-17 2000-08-24 Smithkline Beecham Corporation yybQ
US6270762B1 (en) * 1999-02-26 2001-08-07 Smithkline Beecham Corporation tdk
GB9906437D0 (en) * 1999-03-19 1999-05-12 Smithkline Beecham Biolog Vaccine
US6130069A (en) * 1999-03-24 2000-10-10 Smithkline Beecham Corporation IspA from Streptococcus pneumoniae
WO2000056884A1 (en) * 1999-03-24 2000-09-28 Smithkline Beecham Corporation pksG
WO2000056873A1 (en) * 1999-03-25 2000-09-28 Smithkline Beecham Corporation mvaA
JP4785014B2 (ja) * 1999-03-26 2011-10-05 プロヴァリス・ユーケー・リミテッド 蛋白質
WO2000059514A1 (en) * 1999-04-02 2000-10-12 Smithkline Beecham Corporation Yeaz
WO2000062804A2 (en) * 1999-04-15 2000-10-26 The Regents Of The University Of California Identification of sortase gene
US7101692B2 (en) 1999-04-15 2006-09-05 The Regents Of The University Of California Identification of sortase gene
US6326167B1 (en) * 1999-04-23 2001-12-04 Smithkline Beecham Corp. TktA from Streptococcus pneumoniae
WO2000065026A2 (en) * 1999-04-28 2000-11-02 Smithkline Beecham Corporation YycG
US6245542B1 (en) * 1999-05-06 2001-06-12 Smithkline Beecham Corporation tRNA methyltransferase from Streptococcus pneumoniae
WO2000070075A1 (en) * 1999-05-17 2000-11-23 Smithkline Beecham Corporation STREPTOCOCCUS PNEUMONIAE yerS
ES2563677T3 (es) 1999-05-19 2016-03-15 Glaxosmithkline Biologicals Sa Composiciones de combinaciones de Neisseria
US6177269B1 (en) * 1999-06-04 2001-01-23 Smithkline Beecham Corporation, aroA
ATE500843T1 (de) * 1999-06-10 2011-03-15 Medimmune Llc Streptococcus pneumoniae proteine und impfstoffe
US6887480B1 (en) * 1999-06-10 2005-05-03 Medimmune, Inc. Streptococcus pneumoniae proteins and vaccines
US6869767B1 (en) * 1999-06-11 2005-03-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Detection of Streptococcus pneumoniae and immunization against Streptococcus pneumoniae infection
US6511839B1 (en) * 1999-06-22 2003-01-28 Pan Fong Chan Fucose kinase
WO2000078785A1 (en) * 1999-06-22 2000-12-28 Smithkline Beecham Corporation lacA
WO2000078784A1 (en) * 1999-06-23 2000-12-28 Smithkline Beecham Corporation treP
US6291230B1 (en) * 1999-06-23 2001-09-18 Smithkline Beecham Corporation Galk promoter
US6884614B1 (en) 1999-07-01 2005-04-26 Basf Aktiengesellschaft Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins
CA2377378A1 (en) * 1999-07-01 2001-01-11 Basf Aktiengesellschaft Corynebacterium glutamicum genes encoding phosphoenolpyruvate:sugar phosphotransferase system proteins
WO2001007460A1 (en) * 1999-07-22 2001-02-01 Smithkline Beecham Corporation FucR
WO2001007463A1 (en) * 1999-07-22 2001-02-01 Smithkline Beecham Corporation Trer
US6277597B1 (en) * 1999-08-03 2001-08-21 Smithkline Beecham Corporation kdtB
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
EP1075841A1 (de) * 1999-08-13 2001-02-14 Erasmus Universiteit Rotterdam Pneumokokkus Impfstoffe
WO2001012649A1 (en) * 1999-08-18 2001-02-22 Smithkline Beecham Corporation Aga
US6168797B1 (en) * 1999-08-18 2001-01-02 Smithkline Beecham Corporation FabF
US6833356B1 (en) 1999-08-25 2004-12-21 Medimmune, Inc. Pneumococcal protein homologs and fragments for vaccines
CA2382795A1 (en) * 1999-08-25 2001-03-01 Medimmune, Inc. Homologs of a pneumococcal protein and fragments for vaccines
WO2001023403A1 (en) * 1999-09-27 2001-04-05 Smithkline Beecham Corporation ypga CLADE GENES
CA2906516C (en) * 1999-09-28 2017-03-07 Geneohm Sciences Canada Inc. Nucleic acids and methods for the detection of streptococcus
WO2001023599A1 (en) * 1999-09-28 2001-04-05 Smithkline Beecham Corporation Streptococcus pneumoniae ykqc
US6861516B1 (en) 1999-10-04 2005-03-01 Merck & Co., Inc. MraY gene and enzyme of pseudomonas aeruginosa
US6951729B1 (en) 1999-10-27 2005-10-04 Affinium Pharmaceuticals, Inc. High throughput screening method for biological agents affecting fatty acid biosynthesis
AU775385B2 (en) * 1999-12-23 2004-07-29 Microscience Limited Virulence genes, proteins, and their use
EP1261630A2 (de) * 1999-12-30 2002-12-04 Bristol-Myers Squibb Company Bakterielle gene und polypeptide essentiell für die zelllebensfähigkeit und ihre verwendungen
US6936432B2 (en) 2000-03-01 2005-08-30 Message Pharmaceuticals Bacterial RNase P proteins and their use in identifying antibacterial compounds
FR2807764B1 (fr) * 2000-04-18 2004-09-10 Agronomique Inst Nat Rech Mutants de bacteries lactiques surproducteurs d'exopolysaccharides
AU5577201A (en) * 2000-04-27 2001-11-07 Med Immune Inc Immunogenic pneumococcal protein and vaccine compositions thereof
EP1734050A3 (de) * 2000-06-12 2012-12-05 University Of Saskatchewan Immunisation von Milchvieh mit GapC Protein gegen Streptococcusinfektion
DK1294771T3 (da) 2000-06-12 2008-12-15 Univ Saskatchewan Kimært GapC-protein fra Streptococcus og anvendelse deraf til vaccinering og diagnosticering
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
ATE343593T1 (de) * 2000-06-12 2006-11-15 Univ Saskatchewan Immunisation von milchvieh mit gapc protein gegen streptococcus infektion
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
HU228706B1 (en) 2000-06-20 2013-05-28 Id Biomedical Corp Streptococcus antigens
WO2002006491A1 (fr) * 2000-07-18 2002-01-24 Center For Advanced Science And Technology Incubation, Ltd. Isopentenyl pyrophosphate isomerase
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
US6821746B2 (en) 2000-10-06 2004-11-23 Affinium Pharmaceuticals, Inc. Methods of screening for FabK antagonists and agonists
US7033795B2 (en) 2000-10-06 2006-04-25 Affinium Pharmaceuticals, Inc. FabK variant
US7048926B2 (en) 2000-10-06 2006-05-23 Affinium Pharmaceuticals, Inc. Methods of agonizing and antagonizing FabK
US7056697B2 (en) 2000-10-06 2006-06-06 Affinium Pharmaceuticals, Inc. FabK variant
EP1330473A2 (de) * 2000-10-26 2003-07-30 Imperial College Innovations Limited Streptokokken-gene
NZ583028A (en) 2000-10-27 2011-10-28 Novartis Vaccines & Diagnostic Nucleic acids and proteins from streptococcus groups A & B
WO2002053761A2 (en) * 2000-12-28 2002-07-11 Wyeth Recombinant protective protein from $i(streptococcus pneumoniae)
EP1227152A1 (de) * 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bakterienstamm und Genom des Bifidobacteriums
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
EP2277897A1 (de) * 2001-04-16 2011-01-26 Wyeth Holdings Corporation Polypeptideantigene codierende offene Leseraster aus Streptococcus pneumoniae und Verwendungen davon
WO2003054007A2 (en) * 2001-12-20 2003-07-03 Shire Biochem Inc. Streptococcus antigens
US20030211470A1 (en) * 2002-03-15 2003-11-13 Olson William C. CD4-IgG2-based salvage therapy of HIV-1 infection
US20030199603A1 (en) * 2002-04-04 2003-10-23 3M Innovative Properties Company Cured compositions transparent to ultraviolet radiation
ES2575014T3 (es) 2002-08-02 2016-06-23 Glaxosmithkline Biologicals S.A. Composiciones de vacuna contra Neisseria que comprenden una combinación de antígenos
WO2004020609A2 (en) * 2002-08-30 2004-03-11 Tufts University Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
EP1540559B1 (de) * 2002-09-13 2013-02-27 The Texas A & M University System Bioinformatisches verfahren zum identifizieren von oberflächenverankerten proteinen aus gram-positiven bakterien und dadurch erhaltene proteine
TWI332843B (en) 2002-11-01 2010-11-11 Glaxosmithkline Biolog Sa Immunogenic composition
FR2846668B1 (fr) * 2002-11-05 2007-12-21 Univ Aix Marseille Ii Identification moleculaire des bacteries du genre streptococcus et genres apparentes
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
WO2004048575A2 (en) * 2002-11-26 2004-06-10 Id Biomedical Corporation Streptococcus pneumoniae surface polypeptides
GB0302699D0 (en) * 2003-02-06 2003-03-12 Univ Bradford Immunoglobulin
CN1774447B (zh) * 2003-04-15 2011-04-06 英特塞尔股份公司 肺炎链球菌抗原
PL1648500T3 (pl) 2003-07-31 2014-12-31 Novartis Vaccines & Diagnostics Inc Kompozycje immunogenne dla Streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
ATE474595T1 (de) 2003-10-02 2010-08-15 Glaxosmithkline Biolog Sa B. pertussis antigene und ihre verwendung bei der vakzinierung
KR101289649B1 (ko) 2003-11-10 2013-08-09 유에이비 리서치 파운데이션 세균의 운반 및 ｃｎｓ 침입을 감소시키기 위한 조성물 및이를 이용한 방법
WO2005063973A1 (en) * 2003-11-26 2005-07-14 Binax, Inc. Methods and kits for predicting an infectious disease state
EP1607485A1 (de) * 2004-06-14 2005-12-21 Institut National De La Sante Et De La Recherche Medicale (Inserm) Quantifizierungsverfahren für die VEGF-121 Isoform in einer biologischen Probe
JP2008504292A (ja) 2004-06-24 2008-02-14 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド 免疫増強用の化合物
EP1768662A2 (de) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner moleküle und assays für deren nachweis
JP2008508320A (ja) 2004-07-29 2008-03-21 カイロン コーポレイション Ｓｔｒｅｐｔｏｃｏｃｃｕｓａｇａｌａｃｔｉａｅのようなグラム陽性細菌に対する免疫原性組成物
EP1807446A2 (de) 2004-10-08 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Immunogene und therapeutische zusammensetzungen für pyogene streptokokken
WO2006048753A2 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
JP2006223194A (ja) * 2005-02-17 2006-08-31 Tosoh Corp スタニオカルシン１（ＳＴＣ１）ｍＲＮＡの測定方法
CN103589650A (zh) 2005-03-18 2014-02-19 米克罗比亚公司 产油酵母和真菌中类胡萝卜素的产生
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
US7476733B2 (en) 2005-03-25 2009-01-13 The United States Of America As Represented By The Department Of Health And Human Services Development of a real-time PCR assay for detection of pneumococcal DNA and diagnosis of pneumococccal disease
HUE056842T2 (hu) 2005-06-27 2022-03-28 Pfizer Ireland Pharmaceuticals Immunogén készítmény
US20070059716A1 (en) * 2005-09-15 2007-03-15 Ulysses Balis Methods for detecting fetal abnormality
EP1945247A1 (de) 2005-10-18 2008-07-23 Novartis Vaccines and Diagnostics, Inc. Mukosale und systemische immunisierungen mit alphavirus-replicon-teilchen
US7527801B2 (en) 2005-11-22 2009-05-05 Novartis Vaccines And Diagnostics, Inc. Norovirus and Sapovirus antigens
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
SI1962899T1 (sl) 2005-12-22 2011-11-30 Glaxosmithkline Biolog Sa Pnevmokokna polisaharidna konjugatna vakcina
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CN101374859B (zh) 2006-01-17 2014-11-26 阿恩·福斯格伦 新的表面外露流感嗜血菌蛋白质(蛋白质E；pE)
CA2637598A1 (en) 2006-01-18 2007-02-14 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
CA2646539A1 (en) 2006-03-23 2007-09-27 Novartis Ag Imidazoquinoxaline compounds as immunomodulators
US9182398B2 (en) 2006-04-01 2015-11-10 Medical Service Consultation International, Llc Methods and compositions for detecting fungi and mycotoxins
EP2589668A1 (de) 2006-06-14 2013-05-08 Verinata Health, Inc Analyse seltener Zellen mittels Probentrennung und DNA-Etiketten
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
JP5081243B2 (ja) * 2006-08-17 2012-11-28 ザ ユーエービー リサーチ ファウンデーション 肺炎球菌抗原を被検体における肺炎球菌性肺炎の指標とする方法
WO2008042338A2 (en) 2006-09-28 2008-04-10 Microbia, Inc. Production of carotenoids in oleaginous yeast and fungi
EP1923069A1 (de) * 2006-11-20 2008-05-21 Intercell AG Schutzpeptide gegen S. pneumoniae und diesbezügliche Zusammensetzungen, Verfahren und Verwendungen
US20100183596A1 (en) * 2007-04-12 2010-07-22 Hester Jeanette Bootsma Virulence Factors of Streptoccus Pnuemoniae
CA2688009C (en) * 2007-05-23 2019-04-02 David E. Briles Detoxified pneumococcal neuraminidase and uses thereof
PL2167121T3 (pl) 2007-06-26 2016-01-29 Glaxosmithkline Biologicals Sa Szczepionka zawierająca koniugaty polisacharydu otoczkowego streptococcus pneumoniae
GB0713880D0 (en) 2007-07-17 2007-08-29 Novartis Ag Conjugate purification
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
EP2197485B1 (de) 2007-09-12 2015-11-11 GlaxoSmithKline Biologicals SA Gas57-mutantenantigene und gas57-antikörper
PT2235046E (pt) 2007-12-21 2012-10-26 Novartis Ag Formas mutantes de estreptolisina o
CA2716212A1 (en) 2008-02-21 2009-08-27 Novartis Ag Meningococcal fhbp polypeptides
RS54190B1 (en) 2008-03-03 2015-12-31 Novartis Ag COMPOUNDS AND COMPOSITIONS USED AS TLR FACTORS
PL2271360T3 (pl) 2008-04-16 2016-03-31 Glaxosmithkline Biologicals Sa Szczepionka
US20100068718A1 (en) 2008-08-22 2010-03-18 Hooper Dennis G Methods and Compositions for Identifying Yeast
EP2174664A1 (de) 2008-10-07 2010-04-14 Stichting Katholieke Universiteit, more particularly the Radboud University Nijmegen Medical Centre Neue Virulenzfaktoren von Pneumokokken
MX2011007456A (es) 2009-01-12 2011-08-03 Novartis Ag Antigenos del dominio de proteina de superficie de union a colageno tipo b (can_b) en vacunas contra bacteria gram positiva.
BRPI1006850B8 (pt) * 2009-01-19 2021-07-27 Biomerieux Sa processo para determinar a susceptibilidade para contrair infecção nosocomial
BRPI1009828A2 (pt) 2009-03-24 2019-03-12 Novartis Ag adjuvante de proteína de ligação de fator h meningocócica
RU2555757C2 (ru) 2009-03-24 2015-07-10 Новартис Аг Комбинации менингококкового фактор н-связывающего белка и пневмококковых сахаридных конъюгатов
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
WO2010144734A1 (en) 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
EP2443250B8 (de) 2009-06-16 2016-09-21 GlaxoSmithKline Biologicals SA Komplement-vermittelte antikörper-abhängige und opsonische bakterienassays mit hohem durchlauf
MX2012000158A (es) 2009-06-29 2012-06-08 Genocea Biosciences Inc Vacunas y composiciones contra streptococcus pneumoniae.
US8877356B2 (en) 2009-07-22 2014-11-04 Global Oled Technology Llc OLED device with stabilized yellow light-emitting layer
DK2459216T3 (da) 2009-09-02 2013-12-09 Novartis Ag Immunogene sammensætninger omfattende tlr-aktivitetsmodulatorer
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
SG178904A1 (en) 2009-09-10 2012-04-27 Novartis Ag Combination vaccines against respiratory tract diseases
US8962251B2 (en) 2009-10-08 2015-02-24 Medical Service Consultation International, Llc Methods and compositions for identifying sulfur and iron modifying bacteria
IN2012DN03418A (de) * 2009-10-09 2015-10-23 Childrens Medical Center
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
WO2011063264A1 (en) * 2009-11-20 2011-05-26 University Of Chicago Methods and compositions related to immunogenic fibrils
US9408907B2 (en) 2009-12-15 2016-08-09 Glaxosmithkline Biologicals Sa Homogenous suspension of immunopotentiating compounds and uses thereof
JP5781542B2 (ja) 2009-12-30 2015-09-24 ノバルティス アーゲー Ｅ．ｃｏｌｉキャリアタンパク質に結合体化した多糖免疫原
EP2534164A4 (de) * 2010-02-11 2013-09-11 Intelligent Med Devices Inc Oligonukleotide im zusammenhang mit für toxin b, toxin a oder binäres toxin kodierenden clostridium-difficile-genen
US9290550B2 (en) 2010-02-23 2016-03-22 Stitchting Katholieke Universiteit Combination vaccine for Streptococcus
US10113206B2 (en) * 2010-02-24 2018-10-30 Grifols Therapeutics Inc. Methods, compositions, and kits for determining human immunodeficiency virus (HIV)
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
JP2013521770A (ja) 2010-03-10 2013-06-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン組成物
US8808703B2 (en) 2010-03-23 2014-08-19 Tom Yao-Hsiang Wu Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc
WO2011137368A2 (en) 2010-04-30 2011-11-03 Life Technologies Corporation Systems and methods for analyzing nucleic acid sequences
EP2575988A1 (de) 2010-05-28 2013-04-10 Tetris Online, Inc. Interaktive, hybride und asynchrone computerspiel-infrastruktur
US9268903B2 (en) 2010-07-06 2016-02-23 Life Technologies Corporation Systems and methods for sequence data alignment quality assessment
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
US9127321B2 (en) * 2010-10-06 2015-09-08 The Translational Genomics Research Institute Method of detecting Coccidioides species
WO2012072769A1 (en) 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
KR20140017554A (ko) 2011-01-20 2014-02-11 제노시아 바이오사이언스, 인크. 폐렴 구균에 대한 백신 및 조성물
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
WO2012138470A2 (en) 2011-04-04 2012-10-11 Intelligent Medical Devices, Inc. Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group b streptococcus
CN108714212B (zh) 2011-05-11 2024-09-06 儿童医疗中心有限公司 多抗原提呈免疫原性组合物及其方法和用途
US20140072622A1 (en) 2011-05-17 2014-03-13 Glaxosmithkline Biologicals S.A. Vaccine against streptococcus pneumoniae
CN104519910B (zh) 2012-03-07 2017-05-03 诺华股份有限公司 肺炎链球菌抗原的含佐剂制剂
RU2644340C2 (ru) 2012-06-14 2018-02-08 Новартис Аг Вакцины для менингококка серогруппы х
AU2013326584B2 (en) 2012-10-02 2016-12-01 Glaxosmithkline Biologicals Sa Nonlinear saccharide conjugates
CN105188747A (zh) 2013-02-01 2015-12-23 葛兰素史密斯克莱生物公司 包含toll样受体激动剂的免疫组合物的皮内递送
ES2959258T3 (es) * 2013-02-07 2024-02-22 Childrens Medical Center Antígenos proteicos que proporcionan protección contra la colonización y/o la enfermedad neumocócicas
WO2015188899A1 (en) * 2014-06-12 2015-12-17 Deutsches Krebsforschungszentrum Novel ttv mirna sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention
EP3077410B1 (de) 2013-12-03 2021-02-03 Virometix AG Prolinreiche lipopeptide zum schutz vor pneumokokken
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
EP3613764A1 (de) * 2014-10-15 2020-02-26 Xenothera Zusammensetzung mit verminderter immunogenität
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
JP6399589B2 (ja) * 2014-10-28 2018-10-03 国立大学法人山口大学 肺炎球菌における発現プロモーター
WO2017023855A1 (en) * 2015-07-31 2017-02-09 The General Hospital Corporation Protein prostheses for mitochondrial diseases or conditions
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
US10993971B2 (en) 2015-12-04 2021-05-04 Dana-Farber Cancer Institute, Inc. Vaccination with MICA/B alpha 3 domain for the treatment of cancer
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
AU2018243910B2 (en) 2017-03-28 2025-04-10 The Children's Medical Center Corporation A multiple antigen presenting system (MAPS)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof
US10525119B2 (en) * 2017-03-31 2020-01-07 Boston Medical Center Corporation Methods and compositions using highly conserved pneumococcal surface proteins
CN111065417B (zh) 2017-06-23 2024-04-19 美商艾芬尼维克斯公司 免疫原性组合物
CN111683678B (zh) 2017-12-06 2024-01-26 默沙东有限责任公司 包含肺炎链球菌多糖蛋白缀合物的组合物及其使用方法
EA202091931A1 (ru) 2018-02-12 2020-11-05 Иниммьюн Корпорейшн ЛИГАНДЫ Toll-ПОДОБНЫХ РЕЦЕПТОРОВ
EP3824019A1 (de) 2018-07-19 2021-05-26 GlaxoSmithKline Biologicals SA Verfahren zur herstellung von getrockneten polysacchariden
CA3111459A1 (en) 2018-09-12 2020-03-19 Affinivax, Inc. Multivalent pneumococcal vaccines
KR20210088535A (ko) 2018-09-12 2021-07-14 더 칠드런스 메디칼 센터 코포레이션 폐렴구균 융합 단백질 백신
JP7275277B2 (ja) 2018-12-19 2023-05-17 メルク・シャープ・アンド・ドーム・エルエルシー ストレプトコッカス・ニューモニエ多糖－タンパク質コンジュゲートを含む組成物およびその使用方法
US20220387614A1 (en) 2019-11-22 2022-12-08 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
EP4240841A1 (de) 2020-11-04 2023-09-13 Eligo Bioscience Aus phagen gewonnene partikel zur in-situ-abgabe von dna-nutzlast in eine c. acnes-population
US20250000962A1 (en) * 2021-07-29 2025-01-02 Université de Lausanne Pneumococcal polypeptide antigens
EP4398933A1 (de) 2021-09-09 2024-07-17 Affinivax, Inc. Multivalente pneumokokken-impfstoffe

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4433092A (en) 1981-03-09 1984-02-21 Champion Spark Plug Company Green ceramic of lead-free glass, conductive carbon, silicone resin and AlPO4, useful, after firing, as an electrical resistor
ATE81722T1 (de) 1984-07-24 1992-11-15 Coselco Mimotopes Pty Ltd Verfahren zur bestimmung von mimotopen.
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
LU86128A1 (fr) 1985-10-18 1987-06-02 Vander Poorten Henri Procede permettant l'impression ou le revetement de ceramique simultanement a son electroformage et conduisant en monocuisson a des produits decoratifs ou techniques
GB8904762D0 (en) * 1989-03-02 1989-04-12 Glaxo Group Ltd Biological process
EP0394827A1 (de) 1989-04-26 1990-10-31 F. Hoffmann-La Roche Ag Chimärische CD4-Immunoglobulin-Polypeptide
US6251581B1 (en) * 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
WO1993010238A1 (en) * 1991-11-14 1993-05-27 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Pneumococcal fimbrial protein a vaccines
AU682340B2 (en) * 1993-01-28 1997-10-02 Regents Of The University Of California, The TATA-binding protein associated factors, nucleic acids encoding TAFs, and methods of use
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
US5480971A (en) 1993-06-17 1996-01-02 Houghten Pharmaceuticals, Inc. Peralkylated oligopeptide mixtures
US5928900A (en) 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
US5474905A (en) * 1993-11-24 1995-12-12 Research Corporation Technologies Antibodies specific for streptococcus pneumoniae hemin/hemoglobin-binding antigens
EP0687688A1 (de) 1993-12-17 1995-12-20 Universidad De Oviedo Antikörper gegen neumolysin und ihre verwendung
EP0804582A1 (de) * 1994-05-16 1997-11-05 The Uab Research Foundation $i(STREPTOCOCCUS PNEUMONIAE) KAPSULÄRE POLYSACCHARIDGENEN UND FLANKIERENDE REGIONEN
SE9404072D0 (sv) 1994-11-24 1994-11-24 Astra Ab Novel polypeptides
US5620190A (en) 1994-08-18 1997-04-15 Fisher-Price, Inc. In-line skate
US5565204A (en) 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US6001564A (en) * 1994-09-12 1999-12-14 Infectio Diagnostic, Inc. Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
JPH08116973A (ja) 1994-10-25 1996-05-14 Yotsuba Nyugyo Kk 新規アミノペプチダーゼとそれをコードするアミノペプチダーゼ遺伝子
CA2218741A1 (en) * 1995-04-21 1996-10-24 Human Genome Sciences, Inc. Nucleotide sequence of the haemophilus influenzae rd genome, fragments thereof, and uses thereof
WO1997043304A1 (en) 1996-05-14 1997-11-20 Smithkline Beecham Corporation Novel compounds
CA2269663A1 (en) * 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae antigens and vaccines
US5958730A (en) 1996-12-13 1999-09-28 Eli Lilly And Company Streptococcus pneumoniae gene sequence FtsY
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US7153952B1 (en) * 1997-07-02 2006-12-26 sanofi pasteur limited/sanofi pasteur limitée Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
CA2305016A1 (en) * 1997-09-24 1999-04-01 Regents Of The University Of Minnesota Human complement c3-degrading proteinase from streptococcus pneumoniae
US6251588B1 (en) * 1998-02-10 2001-06-26 Agilent Technologies, Inc. Method for evaluating oligonucleotide probe sequences
IL142017A0 (en) * 1998-09-24 2002-03-10 Univ Minnesota Human complement c3-degrading polypeptide from streptococcus pneumoniae
US6582706B1 (en) * 1998-12-21 2003-06-24 Medimmune, Inc. Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS

Also Published As

Publication number Publication date
DK0942983T3 (da) 2007-04-30
EP1770164A3 (de) 2007-10-10
DE69739981D1 (de) 2010-10-14
US6929930B2 (en) 2005-08-16
ES2277362T5 (es) 2014-12-18
WO1998018930A3 (en) 1998-10-08
AU5194598A (en) 1998-05-22
AU3140701A (en) 2001-06-28
US8168205B2 (en) 2012-05-01
US7056510B1 (en) 2006-06-06
WO1998018931A2 (en) 1998-05-07
US20020032323A1 (en) 2002-03-14
ES2277362T3 (es) 2007-07-01
US7141418B2 (en) 2006-11-28
AU2004210523B2 (en) 2007-01-04
PT942983E (pt) 2007-02-28
AU2004210523A1 (en) 2004-10-07
DE69737125D1 (de) 2007-02-01
CA2271720A1 (en) 1998-05-07
EP1770164B1 (de) 2010-09-01
JP4467606B2 (ja) 2010-05-26
US20050181439A1 (en) 2005-08-18
DE69737125T3 (de) 2015-02-26
JP2008022854A (ja) 2008-02-07
AU2007200944A1 (en) 2007-03-22
JP2009039110A (ja) 2009-02-26
EP0941335A2 (de) 1999-09-15
US6420135B1 (en) 2002-07-16
AU6909098A (en) 1998-05-22
AU773895B2 (en) 2004-06-10
JP4469026B2 (ja) 2010-05-26
AU2011200622A1 (en) 2011-03-03
JP2001505415A (ja) 2001-04-24
EP0942983B2 (de) 2014-09-10
US20100221287A1 (en) 2010-09-02
CA2269663A1 (en) 1998-05-07
DE69737125T2 (de) 2007-10-25
JP2008035865A (ja) 2008-02-21
ATE348887T1 (de) 2007-01-15
JP2001501833A (ja) 2001-02-13
US20100196410A1 (en) 2010-08-05
WO1998018931A3 (en) 1998-08-20
EP1770164A2 (de) 2007-04-04
ES2350491T3 (es) 2011-01-24
US6573082B1 (en) 2003-06-03
EP1400592A1 (de) 2004-03-24
US20040029118A1 (en) 2004-02-12
WO1998018930A2 (en) 1998-05-07
JP2008178407A (ja) 2008-08-07
US20070154986A1 (en) 2007-07-05
US20020061545A1 (en) 2002-05-23
EP0942983A2 (de) 1999-09-22
EP0942983B1 (de) 2006-12-20
DK0942983T4 (en) 2014-12-01

Similar Documents

Publication Publication Date Title
DE69739981D1 (de) Streptococcus pneumoniae-Antigene und Impfstoffe
EP2261358A3 (de) Streptokokken-Antigene
WO1999042588A3 (en) Group b streptococcus antigens
DE69935986D1 (de) Streptococcus pneumoniae proteine und nukleinsäuren
WO2001098334A3 (en) Streptococcus antigens
BR0015137A (pt) Peptìdeos antigênicos de neisseria
AU2001294541A1 (en) Mammalian genes; related reagents and methods
DK602087A (da) Plasmid, bakterie indeholdende plasmidet, monoklonalt antistof derfor og fremgangsmaade til identificering af haemophilus influenza
DE69735715D1 (de) Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird
WO2000005378A3 (en) Streptococcus suis vaccines and diagnostic tests
PT1219711E (pt) Vacina de lawsonia intracellularis
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
ATE109512T1 (de) Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind.
HU9401511D0 (en) Vaccine against streptococcus suls infection
WO1995032292A3 (en) Detection of viral antigens coded by reverse-reading frames
ATE315649T1 (de) Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung
WO1999029724A3 (en) Dna encoding pasteurella multocida outer membrane protein
Bopp et al. Comparative studies on novel protein antigens of streptococci of the serological group B
ES2056844T3 (es) Antigeno de treponema hyodysenteriae y sus usos.
EP1950302A3 (de) Streptokokken-Antigene
ATE251215T1 (de) Helicobacter felis impfstoff

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties